• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of August 7, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-1982-13
Classification Class III
Code Info GFKWMV;GFKXMW; GFLCNS; GFLDJG; GFLFPV; GFLGJT; GFLHQF; GFLJHW; GFLKKC; GFMDZG; GFMGBS; GFMGTN; GFMHXS; GFMJMT; GFMKHX; GFMMBQ; GFMMWS; GFMPJS; GFMQFC; GFMRMP; GFMSVC; GFMVBP; GFMPDV; GFYBVS; GFYCYF; GFYFDR; GFYGLW; GFYGYN; GFYJFM; GFYJTT; GFYKZL; GFYLYK; GFYNZL; GFZHLG; GFZJGY; GFZKMW; GFZLNH; GFZMJH; GFZNFN; GFZPFH; GFZPVM; GFZQPL; GFZRGV; JBBRWK; JBBZYZ
Product Distributed Qty 46 units
Reason For Recall Blood products, collected from a donor who was at risk for variant Creutzfeldt-Jakob disease (vCJD), were distributed.

Event Detail

Event Id 39995
Product Type Biologics
Status Terminated
Recalling Firm ZLB Bioplasma, Inc.
City Columbus
State OH
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2005-02-25
Initial Firm Notification of Consignee or Public FAX
Distribution Pattern IL, CA
-
-